Chips · Stock report · Linde (NASDAQ: LIN)
Linde — 63rd of 86 in our chip section as it slips under its 200-day average
The Closelooknet read
Linde (NASDAQ: LIN) ranks 63rd of the 86 stocks in our chip section (which includes suppliers of gases and materials to chipmakers) on one-month move, and our composite score is 48. Our money-flow reading (a gauge of net buying pressure) is 8.8: still positive but slowing, down 9.6 over 21 days. On Wednesday the stock closed at $483.98, below the average close of the last 200 sessions ($487.18). What we watch: whether it climbs back above $487.18 in the coming sessions, or keeps closing under it.
Where Linde stands among our section's stocks
Linde's one-month move of 3.3% places it 63rd of 86 in our chip section. That trails Qnity Electronics (Q) at 5.2% but beats Air Liquide (AI.PA), which fell 2.6%. Ajinomoto (2802.T) in Tokyo gained 3.2%.
On distance from highs, Air Liquide sits 10.6% below its 10 April 52-week high, Ajinomoto 13.4% below its 1 July high and Qnity 26.1% below its 22 June high. Linde is 11.5% below its 2 July high of $546.64.
Our money-flow and quality readings
Our money-flow reading for Linde is 8.8, down 1.7 over five days and 9.6 over 21 days; the label is still positive but slowing.
Linde scores 48 of 100 overall. Capital allocation is its strongest part at 74, then quality at 64 and balance at 50. Momentum (42), growth (40), cash quality (40) and valuation (32) sit below the composite. The Piotroski score is a check of financial health, scored 5 of 9.
Price trend and the Street
Linde fell 1.2% on Wednesday, is up 13.5% this year and is down 7.9% over three months. It trades 1.0% above its 50-day average ($479.07) and 0.7% below its 200-day average ($487.18). The 50-day line crossed below the 200-day line eight sessions before the 6 October alert, a signal known as a death cross. Its typical daily swing is about 1.2%.
Analysts' average target is $557, 13.7% above the last close, with 26 buy, 3 hold and no sell ratings.
Closelooknet is a research diary. Nothing here is investment advice or a recommendation to buy or sell.